» Articles » PMID: 37884554

Comparative Analysis Between 2D and 3D Colorectal Cancer Culture Models for Insights into Cellular Morphological and Transcriptomic Variations

Overview
Journal Sci Rep
Specialty Science
Date 2023 Oct 26
PMID 37884554
Authors
Affiliations
Soon will be listed here.
Abstract

Drug development is a time-consuming and expensive process, given the low success rate of clinical trials. Now, anticancer drug developments have shifted to three-dimensional (3D) models which are more likely to mimic tumor behavior compared to traditional two-dimensional (2D) cultures. A comparative study among different aspects was conducted between 2D and 3D cultures using colorectal cancer (CRC) cell lines, in addition, Formalin-Fixed Paraffin-Embedded (FFPE) block samples of patients with CRC were used for evaluation. Compared to the 2D culture, cells grown in 3D displayed significant (p < 0.01) differences in the pattern of cell proliferation over time, cell death phase profile, expression of tumorgenicity-related genes, and responsiveness to 5-fluorouracil, cisplatin, and doxorubicin. Epigenetically, 3D cultures and FFPE shared the same methylation pattern and microRNA expression, while 2D cells showed elevation in methylation rate and altered microRNA expression. Lastly, transcriptomic study depending on RNA sequencing and thorough bioinformatic analyses showed significant (p-adj < 0.05) dissimilarity in gene expression profile between 2D and 3D cultures involving thousands of genes (up/down-regulated) of multiple pathways for each cell line. Taken together, the study provides insights into variations in cellular morphologies between cells cultured in 2D and 3D models.

Citing Articles

Development of an ALK-positive Non-Small-Cell Lung Cancer in Vitro Tumor 3D Culture Model for Therapeutic Screening.

Berry M, Bland A, Major G, Ashton J J Histochem Cytochem. 2025; 73(1-2):63-79.

PMID: 39991927 PMC: 11851580. DOI: 10.1369/00221554251318435.


PI3Kα-specific inhibitor BYL-719 synergizes with cisplatin in vitro in PIK3CA-mutated ovarian cancer cells.

Thibault B, Thole A, DAngelo R, Basset C, Guillermet-Guibert J Sci Rep. 2025; 15(1):6265.

PMID: 39979449 PMC: 11842864. DOI: 10.1038/s41598-025-90714-9.


A precision oncology-focused deep learning framework for personalized selection of cancer therapy.

Sederman C, Yang C, Cortes-Sanchez E, Di Sera T, Huang X, Scherer S bioRxiv. 2025; .

PMID: 39763776 PMC: 11702554. DOI: 10.1101/2024.12.12.628190.


Leveraging Xenobiotic-Responsive Cancer Stemness in Cell Line-Based Tumoroids for Evaluating Chemoresistance: A Proof-of-Concept Study on Environmental Susceptibility.

Kim K, Lee S, Kim J, Moon Y Int J Mol Sci. 2024; 25(21).

PMID: 39518936 PMC: 11545740. DOI: 10.3390/ijms252111383.


Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.

Dinic J, Jovanovic Stojanov S, Dragoj M, Grozdanic M, Podolski-Renic A, Pesic M Life (Basel). 2024; 14(9).

PMID: 39337925 PMC: 11433531. DOI: 10.3390/life14091142.


References
1.
Gu Y, Preisser J, Zeng D, Shrestha P, Shah M, Simancas-Pallares M . PARTITIONING AROUND MEDOIDS CLUSTERING AND RANDOM FOREST CLASSIFICATION FOR GIS-INFORMED IMPUTATION OF FLUORIDE CONCENTRATION DATA. Ann Appl Stat. 2022; 16(1):551-572. PMC: 8963777. DOI: 10.1214/21-aoas1516. View

2.
Jalili V, Afgan E, Gu Q, Clements D, Blankenberg D, Goecks J . The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update. Nucleic Acids Res. 2020; 48(W1):W395-W402. PMC: 7319590. DOI: 10.1093/nar/gkaa434. View

3.
Liang Z, Li X . Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer. Autoimmunity. 2021; 54(2):76-87. DOI: 10.1080/08916934.2021.1887148. View

4.
Tse H, Gardner G, Dominguez-Bendala J, Fraker C . The Importance of Proper Oxygenation in 3D Culture. Front Bioeng Biotechnol. 2021; 9:634403. PMC: 8042214. DOI: 10.3389/fbioe.2021.634403. View

5.
Luca A, Mersch S, Deenen R, Schmidt S, Messner I, Schafer K . Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One. 2013; 8(3):e59689. PMC: 3608563. DOI: 10.1371/journal.pone.0059689. View